Goldman Sachs’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.43M Sell
26,427
-4,173
-14% -$233K ﹤0.01% 4821
2025
Q4
$1.71M Sell
30,600
-80,694
-73% -$4.18M ﹤0.01% 4727
2025
Q3
$5.34M Sell
111,294
-3,037
-3% -$136K ﹤0.01% 3578
2025
Q2
$4.64M Sell
114,331
-5,598
-5% -$225K ﹤0.01% 3494
2025
Q1
$5.25M Buy
119,929
+59,007
+97% +$2.6M ﹤0.01% 3299
2024
Q4
$2.62M Buy
60,922
+6,316
+12% +$287K ﹤0.01% 4053
2024
Q3
$2.42M Buy
54,606
+14,552
+36% +$623K ﹤0.01% 3988
2024
Q2
$1.59M Sell
40,054
-115,684
-74% -$4.69M ﹤0.01% 4091
2024
Q1
$6.72M Buy
155,738
+55,738
+56% +$2.4M ﹤0.01% 2830
2023
Q4
$4.16M Sell
100,000
-77,043
-44% -$2.92M ﹤0.01% 3318
2023
Q3
$7.04M Sell
177,043
-6,115
-3% -$259K ﹤0.01% 2685
2023
Q2
$7.51M Sell
183,158
-133,979
-42% -$5.53M ﹤0.01% 2728
2023
Q1
$13M Buy
317,137
+50,437
+19% +$2.12M ﹤0.01% 2182
2022
Q4
$10.9M Buy
266,700
+130,565
+96% +$5.44M ﹤0.01% 2503
2022
Q3
$5.47M Buy
136,135
+83,941
+161% +$3.59M ﹤0.01% 3055
2022
Q2
$2.19M Sell
52,194
-455,723
-90% -$19.1M ﹤0.01% 3965
2022
Q1
$23M Sell
507,917
-69,261
-12% -$3.04M 0.01% 1950
2021
Q4
$26.6M Sell
577,178
-49,280
-8% -$2.33M 0.01% 1867
2021
Q3
$29.7M Buy
626,458
+180,825
+41% +$8.99M 0.01% 1697
2021
Q2
$23.1M Sell
445,633
-207,140
-32% -$10.4M 0.01% 1922
2021
Q1
$32.9M Buy
652,773
+28,112
+5% +$1.5M 0.01% 1509
2020
Q4
$32.5M Buy
624,661
+119,789
+24% +$5.73M 0.01% 1465
2020
Q3
$22M Sell
504,872
-97,112
-16% -$4.25M 0.01% 1673
2020
Q2
$25.9M Sell
601,984
-15,732
-3% -$650K 0.01% 1469
2020
Q1
$22.3M Sell
617,716
-246,353
-29% -$10.5M 0.01% 1426
2019
Q4
$39.5M Buy
864,069
+9,596
+1% +$380K 0.01% 1329
2019
Q3
$30.4M Buy
854,473
+172,797
+25% +$6.42M 0.01% 1466
2019
Q2
$27.2M Sell
681,676
-25,580
-4% -$1.01M 0.01% 1612
2019
Q1
$29.4M Sell
707,256
-65,786
-9% -$2.67M 0.01% 1535
2018
Q4
$28.3M Buy
773,042
+306,918
+66% +$13.1M 0.01% 1526
2018
Q3
$22.6M Sell
466,124
-48,100
-9% -$2.28M 0.01% 1829
2018
Q2
$22.1M Sell
514,224
-1,730
-0.3% -$72.7K 0.01% 1805
2018
Q1
$21.6M Buy
515,954
+637
+0.1% +$27.8K 0.01% 1799
2017
Q4
$22.4M Sell
515,317
-410,359
-44% -$17.5M 0.01% 1852
2017
Q3
$39.4M Buy
925,676
+17,328
+2% +$735K 0.01% 1455
2017
Q2
$39.1M Buy
908,348
+122,374
+16% +$5.16M 0.01% 1414
2017
Q1
$32.9M Buy
785,974
+268,882
+52% +$11M 0.01% 1523
2016
Q4
$20.2M Sell
517,092
-211,517
-29% -$8.61M 0.01% 1949
2016
Q3
$32.2M Buy
728,609
+109,994
+18% +$4.99M 0.01% 1541
2016
Q2
$25.9M Sell
618,615
-1,957,882
-76% -$82.9M 0.01% 1605
2016
Q1
$104M Buy
2,576,497
+1,456,640
+130% +$61.7M 0.04% 641
2015
Q4
$57.3M Buy
1,119,857
+505,478
+82% +$25.8M 0.02% 1021
2015
Q3
$28.8M Buy
614,379
+134,869
+28% +$8.12M 0.01% 1450
2015
Q2
$29.9M Buy
479,510
+471,394
+5,808% +$29.4M 0.01% 1503
2015
Q1
$501K Sell
8,116
-300,722
-97% -$17.8M ﹤0.01% 5124
2014
Q4
$16.7M Buy
308,838
+116
+0% +$6.34K 0.01% 1948
2014
Q3
$16.4M Sell
308,722
-694,372
-69% -$35.3M 0.01% 1951
2014
Q2
$52.1M Buy
1,003,094
+641,286
+177% +$30.9M 0.02% 1071
2014
Q1
$16.9M Buy
361,808
+337,268
+1,374% +$15.9M 0.01% 1911
2013
Q4
$1.08M Buy
24,540
+6,942
+39% +$289K ﹤0.01% 4680
2013
Q3
$677K Buy
+17,598
New +$665K ﹤0.01% 4904

Other funds holding XPH